NEWS

letter

Graduate School of Excellence

OKTOBER
2023
Alumni

https://www.mhh.de/hbrs
NEWSletter
Dear HBRS Alumni, Weekend workshop in Berlin Virology. Organizing this ZIB 2023 summer retreat was nothing but
an amazing experience for all of us. It took the dedication and the
We proudly present our 18th HBRS Alumni newsletter. Susanne Kruse and 20 international HBRS students travelled to Ber- collaborative effort of the entire team and we are thrilled to share the
MHH is currently in a phase of substantial transition, reflected by successful as well as ongoing lin from June 30th–July 2nd, 2023. Students from 14 different countries outstanding outcomes and profound impact it had on fostering colla-
formed part of the group. In the mornings, the trainer Grit Kümmele boration and innovation.
replacements of many clinic and institute heads due to a retirement wave. HBRS welcomes all discussed various aspects of integration into the German thinking and
of them and looks forward to enroll their PhD and medical doctorate students and, of course, is way of life as well as conflict management. The cultural program in The planning process started a year prior with an enthusiastic brain-
happy to continue in supporting all our national and international students in all clinics, depart- the afternoons and evenings included a guided bus tour, a guided tour storming session, where ideas for the perfect retreat experience were
ments, and institutes of MHH and its partners. through the Reichstag, as well as a walking tour to Eastside Gallery. shared setting the foundation on which we looked back at every step
The DAAD kindly supported a weekend workshop for specialists from on the way. The organizing committee divided their responsibilities,
In this newsletter, we give an overview of our current activities as well as news and insights from with each member overseeing specific aspects of the event, such as
your fellow Alumni. Thank you for your interest in our work and for your continuous support. third world countries on the topic “Understanding the Germans – In-
tercultural aspects”. The weekend was a great success. The workshop inviting speakers, connecting with companies for their sponsorship,
will certainly be repeated :-). building the retreat booklet, scheduling the event and most import-
Reinhold Förster, Acting Dean of HBRS antly dealing with MHH. A well-defined schedule was created to give a
chance to all students to present their data to others and get feedback.
Current status of HBRS and news As the day of the retreat approached, excitement and anticipation fil-
HBRS currently comprises six international (MD)/PhD pro- Currently, the various programs of HBRS host ~250 PhD students. In led the air. Upon arrival at the serene venue, participants were greeted
grams (“Molecular Medicine”, “Infection Biology / DEWIN”, addition, 25 medical students were accepted for StrucMed, 14 for with warm smiles and a sense of unity. The opening ceremony set the
“Regenerative Sciences”, “Auditory Sciences”, “Epidemiology” KlinStrucMed and 10 for DigiStrucMed this year. About 80 new Master tone for the retreat, emphasizing the value of collaboration and perso-
and “Biomedical Data Science”). There are meanwhile altogether students (in three programs) are enrolled.About 60% of our PhD stu- nal growth within the organization. As our first guest we were able to
three structured doctoral programs for medical students to receive dents are international and around 10% have a medical background. great Prof. Dr. John Ziebuhr with new intel about RNA structures and
the Dr.med. degree (StrucMed; KlinStrucMed and DigiStrucMed). About 50% are women. enzymes involved in alphacoronavirus RNA synthesis and processing.
Three HBRS-associated Master programs “Biomedicine”, “Biochemis- Since 2023, HBRS has been embedded in the newly established De- After him the PhD students of the virology department presented new
try” and “Biomedical Data Science” are established. anery of Academic Career Development lead by Prof. Dr. Anette Melk. insights of their own research, reaching from human cytomegalovirus
to SARS-CoV-2 and a lot of new inspiration was given through various
interested questions.
Fritz Hartmann Lecture After some trepidation thanks to Deutsche Bahn, we were also able to
Opening of study year, October 2022 News from MHH welcome our second guest speaker in the afternoon. Niklas Björkström
• Prof. Florian Heidel was appointed head of the Hematology, Overall MHH received the record sum of 101.4 million Euro of third- from the Karolinska Institute in Stockholm opened the Immunology
Hämostaseology, Oncology and Stem cell Transplantation party funds in 2022. session with his exciting talk about the differentiation, tissue-residen-
department (succession of Prof. Arnold Ganser) cy and recirculation patterns of human natural killer cells. Following
Researchers of the department Experimental Hematology and Fraun-
this talk, the PhD students from the Immunology department excitingly
• Prof. Arjang Ruhparwar is the new head of the HTTG surgery hofer ITEM received 1.5 million Euro for the project iGUARD. The aim is
presented the topics of their past years of research.
(succession of Prof. Axel Haverich). to develop RNA-based therapies.
This thrilling and eventful first day was concluded with the speakers’
• Prof. Maximilian Lenz is new head of the Institute for Neuroanatomy The DFG Research Group FOR2953 “Sialic acids as regulators of de-
dinner, at which the organizing committee met with the guest speakers
and Cell Biology. velopment and immunity” (speaker PD Dr. Martina Mühlenhoff, Clinical
and the representatives of two companies. The evening ended with
Biochemistry) received 4.6 million Euro for the next three years.
• Prof. Gerard Krause (Epidemiology, HZI) moved to the WHO in a lot of good food, many laughter as well as funny and informative
Genève, Switzerland. He will keep a guest scientist status at MHH. Prof. Nico Lachmann (Pediatric Pneumology) received 2.5 million Euro conversations, as we were already looking forward to the day ahead.
of the Fraunhofer Attract program for 5 years. He aims to scale up the
• Prof. Adrian Schwarzer was appointed CCC-MV professor for production of maturated immune cells.
Translational and Experimental Oncology in Greifswald.
Building activities have started for the new Centre for Individualized
• Dr. Bernd Heinrich (Gastroenterology) received the prestigious Medicine (CiiM). It is located right next to Twincore building in Feodor
Christian Drosten, Director Institute of Virology, Charité Berlin (right) with Reinhold Max Eder stipend for his research on liver carcinoma (HCC). Lynen Strasse.
Förster, HBRS (left)
Else Kröner Fresenius Foundation is supporting the new Medical Scien-
Guided tour through Hannover, tist program nextGENERATION with 1 million Euro. Speakers are Prof.
October 2022 Nico Lachmann, Prof. Christine Happle as well as Prof. Robert Zwei-
from professors and supervisors:
gerdt.
• Prof. Moritz Schmelzle became head of the Department for General,
Visceral and Transplant Surgery in October 2022. MHH and partner institutes are currently developing chip-based met-
hods to replace or supplement animal experiments. The R2N project is
• Prof. Nataliya Di Donato is now head of the Human Genetics supported with 3.6 million Euro from EU funds.
department (succession of Prof. Brigitte Schlegelberger)
• Prof. Kai Schmidt-Ott has become head of the Nephrology ZIB Retreat 2023
ZIB Organization Team
department (succession of Prof. Hermann Haller)
Report from the Students’ Organization Committee
The second day was introduced by the third guest speaker, Nelson Ge-
• Prof. Andreas Kispert is now head of the Molecular Biology
The Hannover Medical School and the ZIB program recently played kara from the University Medical Center Freiburg and his interesting
department (succession of Prof. Achim Gossler)
host to a remarkable scientific retreat that brought together PhD stu- insights to the role of intracellular DNA sensors in innate immune pri-
dents and other brilliant minds from Immunology, Microbiology and ming and genome stability. Further, we gained new knowledge about

https://www.mhh.de/hbrs
NEWSletter
a broad range of microbial topics through the dedicated presentations peptide known to block the Toll-like receptor (TLR) adaptor molecu- Figure 1: Modulation of the AAV2. MB453 capsid variant and View from abroad 1
of the PhD students from the microbiology departments. le MyD88 (myeloid differentiation primary response 88) in the AAV2 transgene expression in moDCs. By Marie-Madlen Pust
vector capsid via capsid engineering. The novel capsid variant, AAV2.
After the lunch break, we were able to welcome further guests from The MyD88-derived peptide was inserted at I-453 (highest of three
MB453, displays the MyD88-blocking peptide in a prominent capsid In this section, we will regularly publish short reports of experien-
different companies for our career session, to inspire our career possibi- protrusions) in the AAV2 capsid (A). Three VP3 capsid subunits are de-
position, the highest peak of the capsid, where the peptide folds into ces of our Alumni students as Postdocs etc. abroad! Everybody is
lities with their experiences. Afterwards, they were available at various picted (white, dark gray, and light gray). The highest capsid peak is
helical structures protruding from the capsid (Figure 1A). Furthermore, welcome to contribute.
stands to answer our questions about different products and methods illustrated in green and the inserted peptide is shown in orange (A).
the binding of AAV2.MB453 to its target molecule, MyD88, was pre-
as well as to give us helpful career tips. At the same time, the youn- Human moDCs were incubated with indicated vectors at a GOI of 2.5
dicted. The novel capsid variant demonstrated enhanced transduction
ger PhD students had the opportunity to present their work through x 104. To determine the level of vector transgene expression, cells Hello from Boston, USA
efficiency in primary human cells, including monocyte-derived dendritic
posters. PhD students and supervisors got into lively conversation and were analyzed via flow cytometry 48 h p.t. (A, B). Mean with individual
cells (moDCs) and primary human hepatocyte (PHH) cultures (Figure I finished my PhD in Microbial Ecolo-
many inspiring discussions brought about new insights, approaches donors is depicted in (A) and normalized transduction levels as fold
1B-C). Compared to AAV2 and another capsid-engineered variant, gy and Computational Biology in the
and cooperation talks. The lively conversations and discussions were change in (B) for n = 5 donors with technical triplicates. Mann-Whit-
AAV2.VSSTSPR, developed for transducing DC, the novel AAV2.MB453 Department of Pediatric Pneumology
thus slowly shifted to the „living room“ of the Asta, where a fabulous ney U test was applied to calculate statistical significance. *p < 0.05.
variant, triggered a reduced innate immune response in moDCs as- in January 2022, under the guidance
catering was already waiting. There were many more hours of enthu- Adapted from Bentler et al., Modifying immune responses to adeno-
sessed by measuring the expression levels of prime proinflammatory of Prof. Dr. Dr. Burkhard Tümmler. By
siastic discussion, laughter and eating as the event slowly drew to a associated virus vectors by capsid engineering, Mol Ther Methods Clin
cytokines and chemokines including IL1A, IL1B, IL8 and type I inter- May, I started my postdoctoral appo-
close. Dev (2023). Copyright © Bentler et al., an open access article under
ferons. Moreover, using the intravenous and intramuscular route of ad- intment as computational research
the CC BY-NC-ND 4.0 license.
Thus, two very exciting and eventful days came to an end, which we ministration, we compared adaptive immune responses elicited in mice fellow in Boston.
as the organization committee look back on with satisfaction. We have toward either the parental AAV2 or AAV2.MB453. Mice injected with PhD program “Infection Biology”;
gained many new insights into various topics and are already looking AAV2.MB453 demonstrated a delayed generation of anti-AAV2 IgG2a From Hannover‘s Quiet to Bos-
final exam January 2022; currently
forward to next year and new exciting topics. binding antibodies compared with AAV2 for both administration routes ton‘s Bustle: As I moved from the
Postdoc = computational research
(Figure 2A-B). Cytotoxic CD8+ T cell responses have been observed in familiar halls of MHH to the esteemed
The organization committee fellow at MIT Harvard, BostoN
human clinical trials using AAV vectors and are considered capable of corridors of the MIT-Harvard universe,
lowering the therapeutic benefit of the gene therapy by eliminating I found myself stepping out of the cocoon of a PhD student within
News in Research AAV vector-transduced target cells. CD8+ T cell responses might be the tight-knit HBRS community into Boston‘s vast academic maze. The
directed toward the AAV capsid or the transgene product. ELISpot ana- reassurance of milestone meetings, the routine hunt for signatures fol-
In this section, we will regularly publish short reviews of important lyses revealed reduced levels of anti-transgene CD8+ T cell responses lowing lectures, and the close guidance from our program coordinators
and recent achievements in selected research fields, or useful tips! in cohorts administered with AAV2.MB453 after intravenous as well and supervisors gave way to a vast, anonymous network of high-achie-
Everybody is welcome to contribute. as after intramuscular injection (Figure 2C). At an early time point af- ving professionals recognized globally for their expertise. I suddenly
ter intramuscular administration of the vectors, a reduced CD8+ T cell found myself amidst peers who had excelled academically and garne-
response toward the AAV capsid was also observed for AAV2.MB453- red prestigious publications or awards. The responsibility now rested on
Novel strategy to reduce the immunogenicity of adeno-associated treated compared to AAV2-injected mice (Figure 2D). In summary, we my shoulders to generate innovative, competitive ideas, develop them
virus (AAV) vectors have developed a capsid-engineered AAV2 capsid variant that mitiga- independently, while building a network for collaboration and support.
by Martin Bentler, Institute of Experimental Hematology, MHH tes innate and adaptive immune responses toward AAV vectors. Our I experienced a roller coaster of emotions. Initially overwhelmed, I soon
novel strategy might add to the ongoing developments of more effi- became excited about the resources available to advance my field of
Hello everyone, Figure 2: Reduced adaptive immune responses in vivo with
cient and safer AAV vectors for human gene therapy. Combining our interest. My spirits dropped when I reached the phase where I revisited
my name is Martin Bentler and I gra- AAV2.MB453. my PhD projects, contemplating what else could have been achieved
capsid-engineered variant with recently published strategies to inter-
duated from the MD/PhD program fere with AAV-induced immune responses including the addition of a BALB/c mice were injected intravenously (A, C) or intramuscularly (B, if I had had these resources earlier. Optimism returned as I considered
Molecular Medicine in November TLR9 inhibitory sequence to the vector transgene is the focus of future D) with either 1 x 1011 vg/mouse (A, C, D) or 1 x 1010 vg/mouse (B) leveraging these assets for my up-coming work, but it waned again at
2022. I performed my PhD under the studies. Overall, our research has led to the generation of a novel AAV of either AAV2 or AAV2.MB453 encoding eGFP as transgenes. Serum the thought that returning to Europe after several years would likely
supervision of Prof. Hildegard Büning capsid variant that holds promise for further developing improved vec- was analyzed regarding AAV2-binding antibodies of the IgG2a subtype mean stepping back from this level of opportunity and resources again.
in the Institute of Experimental He- tors for AAV-mediated gene therapies. by ELISA after intravenous (A) and intramuscular (B) administration. MIT, Harvard, Broad: The Triple Helix of Opportunities: After
matology. The research work in the Isolated splenocytes were stimulated with immunodominant epitopes navigating the initial whirlwind of adjustment, I realized that my PhD
institute strongly focuses on develo- for transgene (eGFP; HYLSTQSAL) and AAV2 capsid (QYGSVSTNL + training at HBRS, mentored by Burkhard Tümmler among others, had
ping novel approaches for cell and PQYGYLTL), respectively, and antigen-specific, IFN-y-secreting T cells
Alumnus of MD/PhD program prepared me well for life as an independent scientist. Rather than me-
gene therapy. The research group of were counted. T cells reactive to eGFP after intravenous injection (C)
Molecular Medicine; now Postdoc rely coping in this competitive environment, I enjoyed the liberty and
Hildegard Büning focuses on opti- and to AAV2 capsid after intramuscular injection (D) are depicted. Data privilege of carving out my own research niche, while also branching
mizing adeno-associated virus (AAV) vectors for applications in gene are presented as mean ± SEM for n = 7 mice. Mann-Whitney U test into new territories, unfettered by budgetary concerns. My experimen-
therapy. AAV vectors are the most commonly used tools for in vivo was applied to calculate statistical significance. *p < 0.05; **p < 0.01. tal choices were now solely dictated by what would most effectively
gene therapy and six market approvals in Europe for AAV vector-ba- Adapted from Bentler et al., Modifying immune responses to adeno- address the questions of my projects, rather than being constrained by
sed gene therapy products for spinal muscular atrophy type I, RPE65 associated virus vectors by capsid engineering, Mol Ther Methods Clin financial limitations or the absence of required IT structure. This marked
gene defect causing retinal diseases and hemophilia A and B (among Dev (2023). Copyright © Bentler et al., an open access article under a thrilling leap in my scientific experience and my learning curve conti-
others) underline its vast potential for clinical use. More gene therapies the CC BY-NC-ND 4.0 license. nues to soar. I attend seminars with the leading minds in and outside
using AAV vectors are expected to receive market approval considering
my scientific niche, I engage in interdisciplinary dialogues, including
the large number of advanced-stage clinical trials. However, immune
deep dives into the ethical, societal, and mathematical aspects of ma-
responses toward the AAV vector capsids or vector-encoded transgene
chine learning and biotechnology. Weekly peer meetings and postdoc-
products pose a major challenge to the success of AAV vector-direc-
toral seminars serve as a constant peer review mechanism, allowing for
ted human gene therapies. Aiming to interfere with the induction of
the ongoing refinement of my work. It is demanding to scrutinize and
de novo immune responses, we developed a strategy to reduce the
debate the shortcomings of my research constantly, but it’s even more
innate immune recognition of AAV vectors. Specifically, we inserted a
gratifying to elevate the project’s quality by recalibrating analytical and

https://www.mhh.de/hbrs
NEWSletter
coding strategies regularly. Moreover, for the first time in my career, the effect of NK cell antigens in chronic rejection in solid organ trans- Lobjanidze, Mikhail Magdei, Ariane Nguyen, Wiebke Triebert nee Löbel, Dr. Alice Rovai (PhD program Regenerative Sciences) received the pu-
Boston‘s collaborative environment enabled me to work with pioneers plantation at Roland Jacob’s lab. It ended in 2019, right when the Kevin Ullmann, Rensheng Wan. On June 23rd, 2023 Andriana Stamo- blication award of the German Liver Foundation, amounting to 7500
from industry, shifting my focus from a project-to-project or paper-to- COVID pandemic started. However, after doing a short postdoc, I rea- poulou and Linqun Zheng successfully defended their PhD thesis; and Euro.
paper mentality to a broader emphasis on real-world applications. Un- lized I wanted to shift gears and combine my varied experience and finally Sebastian Andreas Hook on August 24th
like in Europe where industry and academia often operate in separate communication skills to start a career in science communication. Shuyong Zhu (PhD Infection Biology) received 640.000 € for three ye-
Nathalie Fernández (January 2023) and Max Hassenstein (March
orbits, in Boston, they are more integrated, facilitating a quicker tran- ars from the province and central government of China..
I created my own business with the goal of bringing together science, 2023) recently passed their final exams in the PhD program “Epide-
sition from theoretical mathematical frameworks to practical solutions
society, and industry. I had the opportunity to work on exciting projects, miology”.
with societal and biomedical impact. SAMUEL AYODEJI (PhD Infection Biology) received the Best Season
including an eBook explaining gene therapies for the lay audience with
Juan Pablo Marcoleta from the PhD program “Auditory Sciences” Paper Award Spring 2023 of the jGfV
Closing Thoughts: As I look back on the first year of my postdoc ex- the University of Porto. My “over-communicative” personality and wri-
successfully passed his final exam.
perience, I am grateful for my PhD journey at HBRS and the mentorship ting skills were finally paying off! So one thing led to another, and I
Katharina Schimmel (MD/PhD program) received two career develop-
I received. The program shaped me into a competitive problem solver eventually moved to Paris, where I work as a Science Marketing Ma-
ment awards, one from the American Heart Association and the other
by focusing on my personal development as an independent scien- nager for a company that started as my client. My primary expertise is „Your assumptions are your windows on the world. Scrub them off every one from the Parker B Francis Foundation. Both of them are for 3 years
tist. In Boston, I was then able to look more outwards, absorbing new inbound marketing content strategy for biotech companies. once in a while, or the light won‘t come in” and provide her with $0.5 million worth of funding. Based on the two
perspectives and building a network from national and international
Life in France is quite different from Germany - new language, food, Isaac Asimov (1920-1992), Biochemist/Author awards, she was promoted to junior faculty (instructor) at Stanford.
collaborations in both academia and industry. Realizing the potential
and high living costs - and working in the industry is entirely distinct
of this expanding network, I‘ve come to understand that sustained
collaborations will allow me to maintain this level of opportunity and
from academia. However, every field has its challenges, and I greatly Announcements What is…..doing?
enjoy the diversity of my current work. Paris is a very international and
resources, no matter where my career leads me next. So, if you‘re con- Marriages: Many of our students have married Greetings from Kenya!
vibrant city with people from all over the world, which makes me feel
templating a PhD at HBRS, I encourage you to go for it. For those who recently. We know of Razan Jammal, Congratulations!
at home. I am currently working as a lecturer at South Eastern Kenya University
have recently completed their PhD or are nearing the finish line and are
(full-time) and Jomo Kenyatta University of Agriculture and Technology
unsure about what‘s next, consider venturing into an overseas post- My next goal is to share my professional journey with younger scien- Children: There are new “HBRS babies” by Felix
(part-time), supervising postgraduate students (8 Masters and 1 PhD).
doc. While it will be challenging, you are more equipped for what lies tists and provide communication training for PhD candidates. I want to Adams, Alexandra Ingendoh, Razan Jammal, Caroline
Furthermore, I am a principal investigator in the characterization of
ahead than you might realize now. Earning your PhD at HBRS ensures help pave the way for a future generation of scientists better prepared Mangare, Katharina Schimmel, Kristina Thamm
immunological profiles in COVID-19 among the African population.
you possess the essential skills needed to succeed in the next chapters to communicate science - whether to publish research, enhance public Congratulations!
This research project is supported by a research grant from The World
of your professional life. trust, or share innovative technologies to advance scientific achieve-
Academy of Sciences (TWAS) and the Africa-ai-Japan project (Phase 2).
ments. We are often so involved with research that we do not realize
Although I did not talk about Boston‘s stunning surroundings, I do The research also involves collaborations with The Institute of Infecti-
have two impressions to share. First, picture a turkey casually strol-
the importance of communication skills and the abilities we develop in Prizes and grants ous Disease and Molecular Medicine, the University of Cape Town, and
academia. If you want to know more about my work and experience,
ling down the street, keeping me company on my commute to work. the Helmholtz Center for Infectious Research. I have applied for several
feel free to connect with me on LinkedIn. I would love to hear from Some Alumni students were awarded important prizes for their re-
Second, you‘ll find cautionary signs posted along Boston‘s beaches, research grants and am working towards becoming an independent
you!! search achievements or received grants:
alerting visitors to the potential presence of white sharks that might investigator and adept mentor to upcoming researchers in Africa.
join you during your swim (see below).
Final exams Bernard Silenou (PhD program Epidemiology) was one of three awar-
Wishing you well. Kind regards,
dees of the “PhD Award / Friends of HZI”. The ceremony took place in
In November 2022, January and June 2023, twelve students of the Caroline Mangare (Alumna MD/PhD)
June 6, 2023.
MD/PhD program “Molecular Medicine” successfully passed their
final exams (Manfred Anim, Martin Bentler, Ian Bresch, Fiorella Paola
Sonja Groß (MD/PhD program) received the Guido Tarone Award at
Charles Cano, Sonja Groß, Fatema Hasan, Funmilola Josephine Hau-
the Heart Failure Winter Meeting in Les Diablerets (HFA) as well as
kamp, Christopher Jahn, Dimyana Neufeldt, Juliette Nowak, Tom Pie-
the Young Investigator Award at the Heart Failure Conference in Prag
per, Fairouz Qasrawi, Claudio Rodriguez Gonzalez, Maximilian Schinke,
(ESC).
Katrin Teich). The next exams are expected for November 10th, 2023.
The final exams in the PhD programs “Infection Biology” and “DEWIN” Chidiebere Awah (MD/PhD program) has received the X-seed Award If you would like to get in touch with anybody from the huge
took place on January 20th, 2023 (Kris Alvarez, Matthias Bruhn, Nicola of $250,000 from the Deerfield Management and New York City Alumni list, please contact the HBRS office. We will be happy to
Frericks, Alina Matthaei, Samuel Osanyinlusi, Timmy Richardo, Katarzy- Economic Development for the discovery of novel mRNA overwriting assist you!
View from abroad 2 na Szymanska-De Wijs and Eshraq Tantawy), followed by the next ones technology and it‘s application in degrading c-MYC and ERBB2 across
By Thais Langer There is also a HBRS LinkedIn group:
on June 30th, 2023 (Azadeh Azadegan, Luise Krajewski, Felix Mulen- multiple cancers. https://www.linkedin.com/groups/2354739
Hello from Paris ge, Kodwo Appoh Odum, Sunayana Shyam Jandhyala, Tanvi Tikla, Jiayi
Wang and Melina Winkler). The next final exams are scheduled for Ja- Chidiebere has also been awarded the 40 under 40 in Cancer as one of and a LinkedIn ZIB Alumni group:
I joined the HBRS PhD program after https://www.linkedin.com/in/alumni-zib-46756a16b/
nuary 19th, 2024. the top young cancer professionals in the United States-‘‘emerging lea-
working several jobs and studying
ders and rising stars‘‘ as well as the U54 pre-pilot NIH award $15,000 As well as a PhD RegSci LinkedIn group:
worldwide, and I appreciated having
and the Center of Advanced Technology, City University of New York as
my diverse CV chosen by the HBRS Award of HBRS PhD prize a co-PI of $32,000.
https://www.linkedin.com/groups/9084167/
selection committee. I wanted to do
October 2022
my PhD in Germany, and Hannover
was the ideal place - it was afforda- Luis M. Ferreira de Almeida (MD/PhD Impressum and contact: Bank account for donations:
ble, peaceful, and an accessible hub to program Molecular Medicine) HBRS office, OE 9117 Please transfer the donation to the following account:
travel to several places (I travel a lot!). Dr. Susanne Kruse Donations:
MD/PhD program “Molecular Medici-
ne”; final exam January 2019; current- I was passionate about my research On January 27th, 2023, nine students of the PhD Program “Regene- Carl-Neuberg-Str. 1, D-30625 Hannover Gesellschaft der Freunde der MHH e.V.
ly Scientific Marketing Supervisor & topic, which I strongly recommend to rative Sciences” successfully passed their final exams: Randa Ba- Tel. +49-(0)511-532-6011; Fax. -2611 Commerzbank Hannover, SWIFT: COBADEFF250
Content Manager, Elvesys, Paris, France anyone considering a PhD. I studied wadi, Santoshi Biswanath Devadas, Mark-Christian Jaboreck, Khatuna [email protected] IBAN DE3925040066031200300, To: 11000227, HBRS

https://www.mhh.de/hbrs